# Expanded Access Program for Autologous Muscle Derived Cells (AMDCs)

> **NCT04661293** · — · TEMPORARILY_NOT_AVAILABLE · sponsor: **Cook MyoSite**

## Conditions studied

_None listed._

## Interventions

- **BIOLOGICAL:** Autologous Muscle Derived Cells (AMDCs)

## Key facts

- **NCT ID:** NCT04661293
- **Lead sponsor:** Cook MyoSite
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** TEMPORARILY_NOT_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04661293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04661293, "Expanded Access Program for Autologous Muscle Derived Cells (AMDCs)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04661293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*